McKesson Corporation (FRA:MCK)
Germany
· Delayed Price · Currency is EUR 616.00
-1.60 (-0.26%)
Last updated: May 13, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Medical Surgical Solutions |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Solutions Growth |
Log In |
Log In |
Log In |
Log In |
| US Pharmaceutical |
Log In |
Log In |
Log In |
Log In |
| US Pharmaceutical Growth |
Log In |
Log In |
Log In |
Log In |
| Prescription Technology Solutions |
Log In |
Log In |
Log In |
Log In |
| Prescription Technology Solutions Growth |
Log In |
Log In |
Log In |
Log In |
| International |
Log In |
Log In |
Log In |
Log In |
| International Growth |
Log In |
Log In |
Log In |
Log In |
Capex by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Medical Surgical Solutions Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Solutions Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
| US Pharmaceutical Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
| US Pharmaceutical Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
| Prescription Technology Solutions Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
| Prescription Technology Solutions Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
| International Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
| International Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Medical Surgical Solutions Operating Profit |
Log In |
Log In |
Log In |
Log In |
| Medical Surgical Solutions Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
| US Pharmaceutical Operating Profit |
Log In |
Log In |
Log In |
Log In |
| US Pharmaceutical Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
| Prescription Technology Solutions Operating Profit |
Log In |
Log In |
Log In |
Log In |
| Prescription Technology Solutions Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |
| International Operating Profit |
Log In |
Log In |
Log In |
Log In |
| International Operating Profit Growth |
Log In |
Log In |
Log In |
Log In |